BioStock: Spago Nanomedical’s SAB on Tumorad’s potential

Recently, Spago Nanomedical announced that the company has formed a Scientific Advisory Board for the radiopharmaceutical programme Tumorad. BioStock reached out to Dr Austin Smith to learn more about the field and Tumorad’s potential.

Read the interview with Spago Nanomedical's SAB member Dr Austin Smith at biostock.se:

https://www.biostock.se/2023/06/spago-nanomedicals-sab-on-tumorads-potential/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/